Last 48 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Cigna Corporation's quarterly P/E stands at 10.7x, down 37.2% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 28.0% YoY to 7.8x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 12.99 | 10.65 | 14.83 | 10.34 | 14.47 | 16.96 | 13.46 | 32.93 | 15.16 | — | 21.45 | 15.09 | 14.26 |
| — | -37.2% | +10.2% | -68.6% | -4.6% | — | -37.3% | +118.3% | +6.4% | — | -0.8% | +95.1% | +5.8% | |
| P/S Ratio | 0.28 | 0.26 | 0.25 | 0.28 | 0.33 | 0.36 | 0.29 | 0.38 | 0.39 | 0.45 | 0.43 | 0.43 | 0.43 |
| — | -27.7% | -13.6% | -27.6% | -15.0% | -21.7% | -32.3% | -11.7% | -9.5% | +10.6% | -22.0% | -8.0% | -6.1% | |
| P/B Ratio | 1.83 | 1.66 | 1.75 | 1.84 | 2.19 | 2.31 | 1.86 | 2.30 | 2.26 | 2.52 | 1.90 | 1.86 | 1.83 |
| — | -28.0% | -6.0% | -20.2% | -3.0% | -8.4% | -2.3% | +24.1% | +23.6% | +46.9% | -15.5% | -1.8% | +1.3% | |
| P/FCF | 9.05 | 20.39 | 3.14 | 6.15 | — | 14.62 | 3.93 | — | — | 5.73 | 20.01 | 8.77 | 9.94 |
| — | +39.5% | -20.2% | — | — | +155.2% | -80.3% | — | — | +38.6% | +38.7% | +21.1% | -55.9% | |
| EV / EBITDA | 8.48 | 7.84 | 8.89 | 8.04 | 9.24 | 10.90 | 8.97 | 9.64 | 9.44 | 10.71 | 9.85 | 8.95 | 8.94 |
| — | -28.0% | -0.9% | -16.6% | -2.2% | +1.8% | -9.0% | +7.7% | +5.6% | +17.2% | -22.8% | -6.9% | -0.5% | |
| EV / EBIT | 10.93 | 10.00 | 12.35 | 9.97 | 12.20 | 12.09 | 11.02 | 11.76 | 12.05 | 14.00 | 11.73 | 11.02 | 12.01 |
| — | -17.2% | +12.1% | -15.3% | +1.2% | -13.7% | -6.1% | +6.8% | +0.4% | +11.0% | -35.0% | -14.2% | +1.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cigna Corporation's operating margin was 3.4% in Q1 2026, up 0.5 pp QoQ and up 0.4 pp YoY. Gross margin contracted 6.3% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.5% | 9.4% | 7.7% | 8.5% | 11.7% | 10.1% | 9.8% | 10.4% | 10.8% | 11.2% | 12.9% | 13.2% | 12.6% |
| — | -6.3% | -22.1% | -17.8% | +9.0% | -9.6% | -23.5% | -21.6% | -14.4% | -13.7% | +3.4% | +4.0% | -6.8% | |
| Operating Margin | 3.3% | 3.4% | 3.0% | 3.7% | 3.6% | 3.0% | 3.3% | 4.0% | 4.0% | 3.9% | 4.0% | 4.6% | 4.6% |
| — | +14.4% | -10.5% | -8.6% | -9.2% | -23.6% | -17.9% | -11.4% | -12.8% | -9.0% | +5.4% | -3.5% | -12.3% | |
| Net Margin | 2.2% | 2.4% | 1.7% | 2.7% | 2.3% | 2.0% | 2.2% | 1.2% | 2.6% | -0.5% | 2.0% | 2.9% | 3.0% |
| — | +19.6% | -21.5% | +130.8% | -10.9% | +517.5% | +7.7% | -59.6% | -14.9% | -117.8% | -22.8% | -52.9% | -12.2% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 14.3% | 3.9% | 2.9% | 4.5% | 3.8% | 3.2% | 3.4% | 1.8% | 3.7% | -0.6% | 2.2% | 3.1% | 3.2% |
| — | +21.1% | -13.7% | +157.0% | +1.5% | +613.0% | +52.6% | -42.8% | +15.3% | -122.3% | -15.6% | -49.0% | -4.1% | |
| ROA | 3.8% | 1.1% | 0.8% | 1.2% | 1.0% | 0.9% | 0.9% | 0.5% | 1.0% | -0.2% | 0.7% | 0.9% | 1.0% |
| — | +23.1% | -14.0% | +155.6% | +1.0% | +576.6% | +33.5% | -49.8% | +2.4% | -120.9% | -17.8% | -49.4% | -4.0% | |
| ROIC | 10.4% | 2.7% | 2.4% | 2.8% | 2.8% | 2.3% | 2.4% | 2.8% | 2.7% | 2.5% | 2.2% | 2.5% | 2.4% |
| — | +16.2% | -1.7% | -0.7% | +3.1% | -7.9% | +7.8% | +16.0% | +13.2% | +15.8% | +20.2% | +11.1% | +2.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Cigna Corporation's Debt/EBITDA ratio is 10.3x, down from 11.5x last quarter — elevated, raising questions about debt serviceability. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.75 | 0.73 | 0.75 | 0.81 | 0.76 | 0.75 | 0.78 | 0.78 | 0.77 | 0.79 | 0.67 | 0.68 | 0.72 |
| — | -3.4% | -3.1% | +4.5% | -0.9% | -4.9% | +16.2% | +14.0% | +6.8% | +8.6% | -4.9% | -4.3% | -2.6% | |
| Debt / EBITDA | 2.67 | 10.27 | 11.53 | 10.39 | 9.88 | 11.51 | 11.34 | 10.17 | 10.12 | 10.93 | 10.95 | 10.36 | 11.00 |
| — | -10.8% | +1.7% | +2.2% | -2.4% | +5.3% | +3.6% | -1.8% | -8.0% | -7.1% | -13.8% | -7.4% | +1.5% | |
| Current Ratio | 0.85 | 0.82 | 0.85 | 0.83 | 0.79 | 0.78 | 0.84 | 0.86 | 0.83 | 0.83 | 0.77 | 0.73 | 0.73 |
| — | +4.7% | +0.7% | -4.0% | -5.6% | -6.3% | +9.9% | +17.6% | +13.8% | +16.5% | +4.9% | -0.0% | -11.4% | |
| Quick Ratio | 0.72 | 0.71 | 0.72 | 0.73 | 0.68 | 0.69 | 0.73 | 0.77 | 0.74 | 0.75 | 0.65 | 0.64 | 0.64 |
| — | +2.7% | -1.2% | -5.9% | -7.9% | -7.6% | +11.8% | +20.9% | +16.2% | +19.8% | +5.9% | +0.6% | -14.3% | |
| Interest Coverage | 6.50 | 6.61 | 5.86 | 7.61 | 7.00 | 6.59 | 6.34 | 7.03 | 6.58 | 7.12 | 6.59 | 6.69 | 6.10 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying CI stock.
Cigna Corporation's current P/E is 13.0x. The average P/E over the last 4 quarters is 12.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cigna Corporation's current operating margin is 3.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cigna Corporation's business trajectory between earnings reports.